Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:22:18.428Z.
Calculation as of: 2026-10-06T18:22:18.428Z.
Quote observation: 2026-10-06T18:20:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bddae1a009f0b40e7fb659cb125a310776fd64778f9839bff19075a224db575c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$166.45M
Operating Cash Flow Yield
11.08%
TTM Avg
9.90%
3Y Avg
5.86%
5Y Avg
5.29%
Market Cap
$169.18M
Operating Cash Flow Yield
N/A
TTM Avg
13.87%
3Y Avg
13.87%
5Y Avg
13.87%
Market Cap
$169.21M
Operating Cash Flow Yield
18.90%
TTM Avg
12.15%
3Y Avg
6.20%
5Y Avg
6.85%
Market Cap
$164.64M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$170.32M
Operating Cash Flow Yield
N/A
TTM Avg
0.62%
3Y Avg
0.62%
5Y Avg
0.62%
Market Cap
$171.00M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.31M
Operating Cash Flow Yield
N/A
TTM Avg
11.12%
3Y Avg
9.89%
5Y Avg
9.89%
Market Cap
$160.27M
Operating Cash Flow Yield
N/A
TTM Avg
1.28%
3Y Avg
1.28%
5Y Avg
1.28%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nkarta, Inc. (NKTX) | $167.06M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $166.45M | 11.08% | 9.90% | 5.86% | 5.29% |
| MediWound Ltd. (MDWD)vs › | $169.18M | N/A | 13.87% | 13.87% | 13.87% |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.21M | 18.90% | 12.15% | 6.20% | 6.85% |
| Quanterix Corporation (QTRX)vs › | $164.64M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $170.32M | N/A | 0.62% | 0.62% | 0.62% |
| Cue Biopharma, Inc. (CUE)vs › | $171.00M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $173.31M | N/A | 11.12% | 9.89% | 9.89% |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.27M | N/A | 1.28% | 1.28% | 1.28% |
| ProQR Therapeutics N.V. (PRQR)vs › | $174.29M | N/A | 6.78% | 6.78% | 6.78% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
